These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2548298)

  • 1. Hypoxia, almitrine, and peripheral neuropathy.
    Howard P
    Thorax; 1989 Apr; 44(4):247-50. PubMed ID: 2548298
    [No Abstract]   [Full Text] [Related]  

  • 2. Is chronic hypoxaemia and/or hypercapnia of the obstructive patient reversible? The role of almitrine bismesylate.
    Eur J Respir Dis Suppl; 1986; 146():609-718. PubMed ID: 2877898
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolution of peripheral nerve function in hypoxaemic COPD patients taking almitrine bismesylate: a prospective long-term study.
    Lerebours G; Senant J; Moore N; Arnaud F; David P; Ozenne G; Nouvet G
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():203s-206s. PubMed ID: 2825867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral neuropathy during treatment with almitrine.
    Chedru F; Nodzenski R; Dunand JF; Amarenco G; Ghnassia R; Ciaudo-Lacroix C; Said G
    Br Med J (Clin Res Ed); 1985 Mar; 290(6472):896. PubMed ID: 2983821
    [No Abstract]   [Full Text] [Related]  

  • 5. Ten cases of peripheral neuropathy during treatment with almitrine in COPD patients.
    Gerard M; Leger P; Couturier JC; Robert D
    Eur J Respir Dis Suppl; 1986; 146():591-6. PubMed ID: 3023128
    [No Abstract]   [Full Text] [Related]  

  • 6. Almitrine and peripheral neuropathy.
    Suggett AJ; Jarratt JA; Proctor A; Howard P
    Lancet; 1985 Oct; 2(8459):830-1. PubMed ID: 2864548
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease.
    Bell RC; Mullins RC; West LG; Bachand RT; Johanson WG
    Ann Intern Med; 1986 Sep; 105(3):342-6. PubMed ID: 3527011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nocturnal hypoxemia of chronic obstructive bronchopathies and almitrine dimesylate].
    Racineux JL; Hubert P; Meslier N; Monrigal JP
    Rev Med Interne; 1985; 6 Spec No():39-42. PubMed ID: 3834559
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vectarian international multicenter study (VIMS) in hypoxemic chronic bronchitis patients treated by the double-blind placebo method for 1 year. Follow-up of the monitoring of 490 patients].
    Ansquer JC
    Rev Med Interne; 1985; 6 Spec No():31-7. PubMed ID: 3914682
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral neuropathy in patients treated with almitrine dimesylate.
    Gherardi R; Louarn F; Benvenuti C; Perrier M; Lejonc JL; Schaeffer A; Degos JD
    Lancet; 1985 Jun; 1(8440):1247-50. PubMed ID: 2860446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of long-term almitrine therapy on sleep hypoxaemia in patients with chronic airways obstruction.
    Racineux JL; Meslier N; Hubert P
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():183s-184s. PubMed ID: 3690029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral neuropathy in chronic bronchopathy. A study of 128 patients].
    Lerebours G; Nouvet G; Senant J; Moore N; Arnaud F
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():400-2. PubMed ID: 2902611
    [No Abstract]   [Full Text] [Related]  

  • 13. Almitrine bismesylate and hypoxemia in COPD patients (results of an Italian multicentric trial).
    Vulterini S; Dardes N; Moreo GC; Chianese R; Maiorano V; Carnimeo N
    Eur J Respir Dis Suppl; 1986; 146():677-83. PubMed ID: 3536561
    [No Abstract]   [Full Text] [Related]  

  • 14. [Future prospects concerning the clinical application and clinical pharmacology of almitrine dimesylate].
    Duroux P
    Rev Med Interne; 1985; 6 Spec No():59-60. PubMed ID: 3834560
    [No Abstract]   [Full Text] [Related]  

  • 15. Almitrine bismesylate (Vectarion).
    Howard P
    Bull Eur Physiopathol Respir; 1984; 20(2):99-103. PubMed ID: 6722367
    [No Abstract]   [Full Text] [Related]  

  • 16. Almitrine and peripheral neuropathy.
    Wouters EF; Greve LH; Steenhuis ES; Gimeno F
    Lancet; 1988 Aug; 2(8606):336. PubMed ID: 2899747
    [No Abstract]   [Full Text] [Related]  

  • 17. [Almitrine bismesylate. A peripheral chemoreceptor agonist].
    Nielsen SP
    Ugeskr Laeger; 1988 Nov; 150(46):2797-800. PubMed ID: 2905090
    [No Abstract]   [Full Text] [Related]  

  • 18. Almitrine and peripheral neuropathy.
    Louarn F; Gherardi R
    Lancet; 1985 Nov; 2(8463):1068. PubMed ID: 2865544
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nocturnal hypoxemia and hypercapnia in patients with chronic obstructive ventilation disorder. Therapy with almitrine, a peripheral chemoreceptor stimulator].
    Rühle KH; Köhler D; Huber G; Matthys H
    Prax Klin Pneumol; 1985 Jun; 39(6):197-203. PubMed ID: 2862627
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of clinical studies carried out in Italy with almitrine bismesylate.
    Grassi V; Tantucci C; Sorbini CA; Grassi C; Cerveri I; Rampulla C; Bottino G; Giacometti A; Blasi A; Pezza A
    Eur J Respir Dis Suppl; 1986; 146():671-6. PubMed ID: 3536560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.